| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/17/2007 | CA2355050C Process for preparing tricyclic compounds having antihistaminic activity |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2341690C Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 04/17/2007 | CA2299300C Arylpyridazinones as prostaglandin endoperoxide h synthase bisoynthesis inhibitors |
| 04/17/2007 | CA2226082C Photochemically cross-linked polysaccharide derivatives having no photopolymerisable functional groups |
| 04/17/2007 | CA2203592C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 04/17/2007 | CA2178642C Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
| 04/12/2007 | WO2007041634A1 Pyrimidine amide compounds as pgds inhibitors |
| 04/12/2007 | WO2007041630A1 Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
| 04/12/2007 | WO2007041616A1 Piperazine amidines as antiviral agents |
| 04/12/2007 | WO2007041379A1 Met kinase inhibitors |
| 04/12/2007 | WO2007041357A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 04/12/2007 | WO2007041341A2 Identification of anti-cancer compounds and compounds for treating huntington's disease and methods of treatment thereof |
| 04/12/2007 | WO2007041324A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | WO2007041270A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | WO2007040682A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040681A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040440A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040436A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040280A1 Cyclic amine compound and pest control agent |
| 04/12/2007 | WO2007040272A1 Method for production of d-(4-aminomethyl)phenylalanine derivative |
| 04/12/2007 | WO2007040240A1 Optically active cyclic alcohol compound and method for producing same |
| 04/12/2007 | WO2007040238A1 Process for production of optically active 4-hydroxy-1,2,3,4 -tetrahydroquinolines |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007039782A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors |
| 04/12/2007 | WO2007039581A1 Imidazolyl-substituted diazabenzophenone compounds |
| 04/12/2007 | WO2007039580A1 Imidazolyl-substituted benzophenone compounds |
| 04/12/2007 | WO2007039578A1 Imidazolyl-substituted azabenzophenone compounds |
| 04/12/2007 | WO2007039499A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
| 04/12/2007 | WO2007039470A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/12/2007 | WO2007039220A1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 04/12/2007 | WO2007039219A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 04/12/2007 | WO2007039170A1 Antagonists of topoisomerase activity and their use in inhibiting pathological conditions |
| 04/12/2007 | WO2007039146A1 4-carboxy pyrazole derivatives as anti-viral agents |
| 04/12/2007 | WO2007018956A3 Antidiabetic oxazolidinediones and thiazolidinediones |
| 04/12/2007 | WO2006128802A3 3-methanesulfonylquinolines as gaba-b enhancers |
| 04/12/2007 | WO2006114401A3 Novel cyclic amines |
| 04/12/2007 | WO2006078598A3 Mitotic kinesin inhibitors |
| 04/12/2007 | WO2006021458A3 Pyrimidine derivatives |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070082926 Novel polymorphs of racemic, dextrorotatory, and levorotatory enationers of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo- quinoline-3-carboxylic acid hydrochloride and mesylate salts |
| 04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
| 04/12/2007 | US20070082914 4-(4-Methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082906 1-(1-{4-[3-(1,3-oxazol- 2-yl)-6-phenyl-1,2,4- triazin-5- yl]benzyl}piperidin-4- yl)-1,3-dihydro-2H- benzimidazol-2-one; inhibit activity of a serine, threonine protein kinase; hyperproliferative disorders, restenosis, inflammation, autoimmune diseases, allergy, asthma |
| 04/12/2007 | US20070082904 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones field of the invention |
| 04/12/2007 | US20070082899 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082896 4-{[3,5-Bis(trifluoromethyl)benzyl]-[5-(4-carboxybutoxy)pyrimidin-2-yl]}amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; cholesteryl ester transfer protein (CETP) inhibitors; increasing HDL cholesterol; lowering LDL cholesterol; arteriosclerosis, hyperlipidemia |
| 04/12/2007 | US20070082894 Pyrazine-based tubulin inhibitors |
| 04/12/2007 | US20070082889 inhibitors of voltage-gated sodium channels; (R)-2-hydroxy-1-(4-(6-(2-hydroxyphenyl)pyridin-2-yl)piperazin-1-yl)-4-methylpentan-1-one; antiinflammation, arthritis, migraine, neuralgia, epilepsy, neurodegenerative and psychiatric disorders , anxiety and depression, myotonia, arrhythmia; cancer |
| 04/12/2007 | US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes |
| 04/12/2007 | US20070082375 Topically administering to a nail of subject having onychomycosis a therapeutically effective amount of an antifungal compound such as (2R, 3R)-2-(2,4-difluorophenyl)-3-(4-methylen piperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol |
| 04/12/2007 | US20070082067 2-[4-(3-Methoxy-4-pyridin-2-ylphenyl)-2H-1,2,3-triazol-2-yl]pyridine; psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders |
| 04/12/2007 | CA2851103A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | CA2624875A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 04/12/2007 | CA2624524A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | CA2624450A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | CA2624179A1 Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2624031A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/12/2007 | CA2624020A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
| 04/12/2007 | CA2623822A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 04/12/2007 | CA2623813A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | CA2623722A1 Indane derivatives as mch receptor antagonists |
| 04/12/2007 | CA2623348A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | CA2623154A1 Novel fused pyrrole derivative |
| 04/12/2007 | CA2622352A1 Substituted pyrazole compounds |
| 04/12/2007 | CA2621040A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/11/2007 | EP1772452A2 Matrix metalloproteinase inhibitors and uses thereof |
| 04/11/2007 | EP1771456A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 04/11/2007 | EP1771454A1 Hepatitis c inhibitor peptide analogs |
| 04/11/2007 | EP1771453A1 Hepatitis c inhibitor dipeptide analogs |
| 04/11/2007 | EP1771445A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 04/11/2007 | EP1771442A1 Viral polymerase inhibitors |
| 04/11/2007 | EP1771441A1 Novel carboxamides for use as xa inhibitors |
| 04/11/2007 | EP1771440A1 Generic probes for the detection of phosphorylated sequences |
| 04/11/2007 | EP1771439A1 4-pyridinylethylcarboxamide derivatives useful as fungicides |
| 04/11/2007 | EP1771438A1 1-3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists |
| 04/11/2007 | EP1771437A1 New heterocyclic carboxylic acid amide derivatives |
| 04/11/2007 | EP1771436A1 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 04/11/2007 | EP1771429A1 New benzoyl urea derivatives |
| 04/11/2007 | EP1771422A1 Quinazolinone derivatives as parp inhibitors |
| 04/11/2007 | EP1771421A1 N-hydroxyamide derivatives and use thereof |
| 04/11/2007 | EP1771418A2 Large conductance calcium-activated k channel opener |
| 04/11/2007 | EP1771415A1 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 04/11/2007 | EP1771175A1 Phthalazine derivatives as parp inhibitors |
| 04/11/2007 | EP1678164B1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/11/2007 | EP1641756B1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 04/11/2007 | EP1567496B1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 04/11/2007 | EP1480972B1 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 04/11/2007 | EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1351938B1 Phenyl derivatives |
| 04/11/2007 | EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 04/11/2007 | EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents |
| 04/11/2007 | EP1084107B1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |